Dr. Birrer earned his undergraduate degree at Rensselaer Polytechnic Institute and graduated with a BS in Biology. He was accepted into the Medical Scientist Training Program at the Albert Einstein College of Medicine and completed his MD and PhD in 1982 with his principle area of study in microbiology and immunology. He then performed a medical internship and residency at the Massachusetts General Hospital.
Dr. Birrer entered the medical oncology fellowship at the National Cancer Institute in Bethesda, Maryland and upon completion performed a postdoctoral on the molecular genetics of lung cancer. After completing his fellowship, Dr. Birrer joined the faculty at the NCI in the Division of Cancer Treatment as an investigator in 1988. Three years later, Dr. Birrer was appointed as a senior investigator and established the molecular mechanism section in the Division of Cancer Prevention and Control.
Dr. Birrer is recognized nationally and internationally as an expert in gynecologic oncology. He has published over 400 peer reviewed manuscripts and another 30 book chapters and review articles.
In November 2008, Dr. Birrer was appointed Professor of Medicine at the Harvard School of Medicine. In August 2017, Dr. Birrer accepted the position of Director of the Comprehensive Cancer Center at the University of Alabama at Birmingham (UAB). While there, he was a Professor of Medicine, Pathology, and Obstetrics and Gynecology, and the recipient of the Evalina B. Spencer Chair in Oncology. During his tenure, Dr Birrer raised over 40 million dollars in philanthropic funds including a 30 million dollar gift to name the Cancer Center. In addition, during this time he designed and open the first cancer service line at UAB.